Company

Magnolia Neurosciences Corporation

New York company offering software solutions that streamline operations in finance, healthcare and logistics.

About

Magnolia Neurosciences Corporation develops software solutions that streamline operations in finance, healthcare and logistics, mainly for small and medium-sized enterprises and larger corporations. Revenue comes from annual or monthly subscriptions and direct B2B deals. The company is headquartered in New York, US. On November 23, 2021, it raised USD 13.000 mn in a Series A round, bringing its total raised to USD 13.000 mn and giving it a post-money valuation of USD 38.633 mn.

1Funding rounds

8Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in